Literature DB >> 29687433

The Impact of Off-Patent Drug Acquisitions on Prices.

Ravi Gupta1, Alexis Henkel2, Howard P Forman3,4,5, Joseph S Ross6,7,8.   

Abstract

Keywords:  Acquisitions; FDA; Generics; Prescription drugs; Pricing

Mesh：

Substances：

Year:  2018        PMID： 29687433      PMCID： PMC6025665          DOI： 10.1007/s11606-018-4372-3

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

1.  High-cost generic drugs--implications for patients and policymakers.

Authors:  Jonathan D Alpern; William M Stauffer; Aaron S Kesselheim
Journal:  N Engl J Med       Date:  2014-11-13       Impact factor: 91.245

2.  Generic Drug Approvals Since the 1984 Hatch-Waxman Act.

Authors:  Ravi Gupta; Aaron S Kesselheim; Nicholas Downing; Jeremy Greene; Joseph S Ross
Journal:  JAMA Intern Med       Date:  2016-09-01       Impact factor: 21.873

3.  New (Very High) Prices on Old Drugs.

Authors:  Saate Shakil; Rita F Redberg
Journal:  JAMA Intern Med       Date:  2017-11-01       Impact factor: 21.873

4.  High Generic Drug Prices and Market Competition: A Retrospective Cohort Study.

Authors:  Chintan V Dave; Aaron S Kesselheim; Erin R Fox; Peihua Qiu; Abraham Hartzema
Journal:  Ann Intern Med       Date:  2017-07-04       Impact factor: 25.391
  4 in total
  1 in total

1.  Generic Drugs in the United States: Policies to Address Pricing and Competition.

Authors:  Ravi Gupta; Nilay D Shah; Joseph S Ross
Journal:  Clin Pharmacol Ther       Date:  2019-01-10       Impact factor: 6.875
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.